Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guarneri

Showing results (1211-1220 of 1,433) with videos related to

Pageof 144
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trialValentina Guarneri, Maria V Dieci, Gaia Griguolo, et al.
Journal of the National Cancer Institute|September 7, 2023
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancerMaria Vittoria Dieci, PierFranco Conte, Giancarlo Bisagni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2025
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world studyMaria Vittoria Dieci, Grazia Vernaci, Chiara Colangelo, et al.
Stem Cells (Dayton, Ohio)|November 26, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomasGiulia Grisendi, Carlotta Spano, Naomi D'souza, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Aging Cell|December 6, 2013
Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapyRavi Jasuja, James C Costello, Rajan Singh, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 18, 2010
Quality of life and contact dermatitis: a disease-specific questionnaireFabio Ayala, Massimiliano Nino, Gabriella Fabbrocini, et al.
Contact Dermatitis|January 25, 2024
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre studyLuca Stingeni, Caterina Foti, Fabrizio Guarneri, et al.
Clinical and Experimental Dermatology|November 13, 2023
Safety of omalizumab in chronic urticaria during pregnancy: a real-life studyCataldo Patruno, Fabrizio Guarneri, Eustachio Nettis, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Pageof 144

Showing results (1211-1220 of 1,433) with videos related to

Sort By:
Pageof 144
European Journal of Cancer (Oxford, England : 1990)|June 21, 2021
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trialValentina Guarneri, Maria V Dieci, Gaia Griguolo, et al.
Journal of the National Cancer Institute|September 7, 2023
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancerMaria Vittoria Dieci, PierFranco Conte, Giancarlo Bisagni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2025
PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world studyMaria Vittoria Dieci, Grazia Vernaci, Chiara Colangelo, et al.
Stem Cells (Dayton, Ohio)|November 26, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomasGiulia Grisendi, Carlotta Spano, Naomi D'souza, et al.
Bone Marrow Transplantation|June 14, 2019
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myelomaAlexandra Gomez-Arteaga, Tomer M Mark, Danielle Guarneri, et al.
Aging Cell|December 6, 2013
Combined administration of testosterone plus an ornithine decarboxylase inhibitor as a selective prostate-sparing anabolic therapyRavi Jasuja, James C Costello, Rajan Singh, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 18, 2010
Quality of life and contact dermatitis: a disease-specific questionnaireFabio Ayala, Massimiliano Nino, Gabriella Fabbrocini, et al.
Contact Dermatitis|January 25, 2024
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre studyLuca Stingeni, Caterina Foti, Fabrizio Guarneri, et al.
Clinical and Experimental Dermatology|November 13, 2023
Safety of omalizumab in chronic urticaria during pregnancy: a real-life studyCataldo Patruno, Fabrizio Guarneri, Eustachio Nettis, et al.
BMC Cancer|March 20, 2020
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Marina Elena Cazzaniga, Andrea Sbrana, et al.
Pageof 144